Letter: Gene patenting would benefit medical companies, not patients

Share
Related Topics
Sir: It should be understood that the main issue in gene patenting (Letters, 31 July) is not whether patent protection should be offered for the development of an inventive diagnostic kit or of a new vehicle for a genetic therapy. These would be inventions in themselves, thus patentable anyway, and we endorse fully a directive which clarifies the whole situation and protects intellectual property rights when appropriate.

Our objection is to the fact that one article in the directive states:

an element isolated from the human body or otherwise produced by means of a technical process including the structure or partial structure of a gene may constitute a patentable invention, even if the structure of that element is identical to that of a natural element.

Therefore, as it stands, the directive does mean that naturally occurring gene sequences are patentable because, in order to do anything with a gene or gene sequence, it has to be isolated from the body.

Although an industrial application has to be stated, this can be something as simple as looking for faults in the gene. This means that any genetic test, using any technique, would be subject to the payment of royalties and licence fees. A biomedical company would not have to develop an inventive kit or develop a therapy to earn money. Indeed, rather than encourage the development of these tests and therapies, it would create a monopoly in which only the patent holder would gain, without the necessity to do anything inventive. The actual gene itself would probably never be used in therapy without some vector to deliver it to the body. Therefore, any therapy derived from the gene would be subject to a double patent.

It is the wording of this one article in the directive that is so vital. There is no guarantee that this directive, as it is worded, will help patients with genetic disorders. However, it will cost the NHS dearly, probably restrict access to genetic tests and create a field day for biomedical companies and lawyers.

ROBERTA TWEEDY

Director, The Neurofibromatosis Association

Kingston upon Thames, Surrey

React Now

Latest stories from i100
Have you tried new the Independent Digital Edition apps?
iJobs Job Widget
iJobs General

Project Coordinator

Competitive: The Green Recruitment Company: The Organisation: The Green Recrui...

Project Manager (HR)- Bristol - Upto £400 p/day

£350 - £400 per annum + competitive: Orgtel: Project Manager (specializing in ...

Embedded Linux Engineer

£40000 - £50000 per annum + competitive: Progressive Recruitment: Embedded Sof...

Senior Hardware Design Engineer - Broadcast

£50000 - £65000 per annum + Benefits: Progressive Recruitment: Working for a m...

Day In a Page

Read Next
The Lada became a symbol of Russia’s failure to keep up with Western economies  

Our sanctions will not cripple Russia. It is doing a lot of the dirty work itself

Hamish McRae
The Israeli ambassador to the US, Ron Dermer, has been dubbed ‘Bibi’s brain’  

Israel's propaganda machine is finally starting to misfire

Patrick Cockburn
Save the tiger: The animals bred for bones on China’s tiger farms

The animals bred for bones on China’s tiger farms

The big cats kept in captivity to perform for paying audiences and then, when dead, their bodies used to fortify wine
A former custard factory, a Midlands bog and a Leeds cemetery all included in top 50 hidden spots in the UK

A former custard factory, a Midlands bog and a Leeds cemetery

Introducing the top 50 hidden spots in Britain
Ebola epidemic: Plagued by fear

Ebola epidemic: Plagued by fear

How a disease that has claimed fewer than 2,000 victims in its history has earned a place in the darkest corner of the public's imagination
Chris Pratt: From 'Parks and Recreation' to 'Guardians of the Galaxy'

From 'Parks and Recreation' to 'Guardians of the Galaxy'

He was homeless in Hawaii when he got his big break. Now the comic actor Chris Pratt is Hollywood's new favourite action star
How live cinema screenings can boost arts audiences

How live cinema screenings can boost arts audiences

Broadcasting plays and exhibitions to cinemas is a sure-fire box office smash
Shipping container hotels: Pop-up hotels filling a niche

Pop-up hotels filling a niche

Spending the night in a shipping container doesn't sound appealing, but these mobile crash pads are popping up at the summer's biggest events
Native American headdresses are not fashion accessories

Feather dust-up

A Canadian festival has banned Native American headwear. Haven't we been here before?
Boris Johnson's war on diesel

Boris Johnson's war on diesel

11m cars here run on diesel. It's seen as a greener alternative to unleaded petrol. So why is London's mayor on a crusade against the black pump?
5 best waterproof cameras

Splash and flash: 5 best waterproof cameras

Don't let water stop you taking snaps with one of these machines that will take you from the sand to meters deep
Louis van Gaal interview: Manchester United manager discusses tactics and rebuilding after the David Moyes era

Louis van Gaal interview

Manchester United manager discusses tactics and rebuilding after the David Moyes era
Will Gore: The goodwill shown by fans towards Alastair Cook will evaporate rapidly if India win the series

Will Gore: Outside Edge

The goodwill shown by fans towards Alastair Cook will evaporate rapidly if India win the series
The children were playing in the street with toy guns. The air strikes were tragically real

The air strikes were tragically real

The children were playing in the street with toy guns
Boozy, ignorant, intolerant, but very polite – The British, as others see us

Britain as others see us

Boozy, ignorant, intolerant, but very polite
How did our legends really begin?

How did our legends really begin?

Applying the theory of evolution to the world's many mythologies
Watch out: Lambrusco is back on the menu

Lambrusco is back on the menu

Naff Seventies corner-shop staple is this year's Aperol Spritz